+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026

  • ID: 4761238
  • Report
  • 170 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Covance Inc.
  • Evotec (Us), Inc.
  • Icon Plc
  • Inventiv Health
  • Parexel International
  • Quintiles
  • MORE
The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to this report. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the

Further key findings from the report suggest:
  • Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
  • Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
  • North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
  • Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
  • Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Covance Inc.
  • Evotec (Us), Inc.
  • Icon Plc
  • Inventiv Health
  • Parexel International
  • Quintiles
  • MORE

Chapter 1 Report Scope

1.1 Segment Market Scope
1.2 Regional Scope

Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information Or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.2 Volume Price Analysis (Model 2)
2.7 List Of Secondary Sources
2.8 List Of Primary Sources
2.9 List Of Abbreviations

Chapter 3 Objectives
3.1 Objective - 1:
3.2 Objective - 2:
3.3 Objective - 3:
3.4 Objective - 4:

Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights

Chapter 5 In Vivo CRO Market: Variables, Trends & Scope
5.1 Market Lineage Outlook
5.1.1 Parent Market Outlook
5.1.2 Ancillary Market Outlook
5.2 Penetration & Growth Prospect Mapping
5.3 Product Pipeline Analysis, By Stage
5.4 User Perspective Analysis
5.4.1 Consumer Behavior Analysis
5.4.2 Market Influencer Analysis
5.5 List Of Key End-Users, By Region / By Product / By Country
5.6 Regulatory Framework
5.6.1 Reimbursement Framework
5.6.2 Standards & Compliances
5.7 Market Variable Analysis
5.7.1 Market Driver Analysis
5.7.1.1 Changing Regulatory Landscape
5.7.1.2 Increase In Offshoring Medical Device Manufacturing To Emerging Countries
5.7.1.3 Rising Demand For Advanced Products
5.7.1.4 Implementation Of International Standards By Contract Manufacturers
5.7.1.5 Rising Price Competition And Requirement To Reduce Cost
5.7.1.6 Increasing Complexity With Respect To Product Design And Engineering
5.7.2 Market Restraint Analysis
5.7.2.1 Compliance Issues While Outsourcing
5.7.2.2 Changing Scenarios In Developing Countries
5.7.2.3 Regulatory And Legal Compliance
5.7.2.4 Contractual Obligation
5.7.3 Industry Challenges
5.8 In Vivo CRO Market: Analysis Tools
5.8.1 Porter’s Five Forces Analysis
5.8.2 Pestel Analysis
5.8.3 Major Deals & Strategic Alliances Analysis
5.8.3.1 Joint Ventures
5.8.3.2 Mergers & Acquisitions
5.8.3.3 Licensing & Partnership
5.8.3.4 Technology Collaborations
5.8.3.5 Strategic Divestments
5.8.4 Market Entry Strategies

Chapter 6 In Vivo CRO Market: Services Segment Analysis
6.1 In Vivo CRO Market: Definition & Scope
6.2 In Vivo CRO Market: Segment Dashboard
6.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
6.4 Rodent Based In Vivo GLP Type
6.4.1 Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
6.4.2 Rats Based In Vivo CRO
6.4.2.1 Rats Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
6.4.3 Mice Based In Vivo CRO
6.4.3.1 Mice Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
6.4.4 Others
6.4.4.1 Others Market, 2014 - 2026 (USD Billion)
6.5 Non-Rodent Based In Vivo GLP Type
6.5.1 Non-Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
6.5.2 Hamsters Based In Vivo CRO
6.5.2.1 Hamsters Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
6.5.3 Guinea Pigs Based In Vivo CRO
6.5.3.1 Guinea Pigs Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
6.5.4 Gerbils Based In Vivo CRO
6.5.4.1 Gerbils Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
6.5.5 Others Based In Vivo CRO
6.5.5.1 Others Based In Vivo CRO Market, 2014 - 2026 (USD Billion)

Chapter 7 In Vivo CRO Market: Type Segment Analysis
7.1 In Vivo CRO Market: Definition & Scope
7.2 In Vivo CRO Market: Segment Dashboard
7.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
7.4 Non GLP
7.4.1 Non GLP Market, 2014 - 2026 (USD Billion)
7.4.2 In House
7.4.2.1 In House Market, 2014 - 2026 (USD Billion)
7.4.3 Outsourcing
7.4.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)
7.5 GLP Toxicology
7.5.1 GLP Toxicology Market, 2014 - 2026 (USD Billion)
7.5.2 In House
7.5.2.1 In House Market, 2014 - 2026 (USD Billion)
7.5.3 Outsourcing
7.5.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)

Chapter 8 In Vivo CRO Market: Indication Segment Analysis
8.1 In Vivo CRO Market: Definition & Scope
8.2 In Vivo CRO Market: Segment Dashboard
8.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
8.4 Autoimmune/ Inflammatory Conditions
8.4.1 Autoimmune/ Inflammatory Conditions Market, 2014 - 2026 (USD Billion)
8.4.2 Rheumatoid Arthritis
8.4.2.1 Rheumatoid Arthritis Market, 2014 - 2026 (USD Billion)
8.4.3 Multiple Sclerosis
8.4.3.1 Multiple Sclerosis Market, 2014 - 2026 (USD Billion)
8.4.4 Osteoarthritis
8.4.4.1 Osteoarthritis Market, 2014 - 2026 (USD Billion)
8.4.5 IrriTable Bowel Syndrome
8.4.5.1 IrriTable Bowel Syndrome Market, 2014 - 2026 (USD Billion)
8.4.6 Others
8.4.6.1 Others Market, 2014 - 2026 (USD Billion)
8.5 Pain Management
8.5.1 Pain Management Market, 2014 - 2026 (USD Billion)
8.5.2 Chronic Pain
8.5.2.1 Chronic Pain Market, 2014 - 2026 (USD Billion)
8.5.3 Acute Pain
8.5.3.1 Acute Pain Market, 2014 - 2026 (USD Billion)
8.6 Oncology
8.6.1 Oncology Market, 2014 - 2026 (USD Billion)
8.6.2 Blood Cancer
8.6.2.1 Blood Cancer Market, 2014 - 2026 (USD Billion)
8.6.3 Solid Tumor
8.6.3.1 Solid Tumor Market, 2014 - 2026 (USD Billion)
8.6.3.2 Syngeneic Model
8.6.3.2.1 Syngeneic Model Market, 2014 - 2026 (USD Billion)
8.6.3.3 Patient Derived Xenograft
8.6.3.3.1 Patient Derived Xenograft Market, 2014 - 2026 (USD Billion)
8.6.3.4 Xenograft
8.6.3.4.1 Xenograft Market, 2014 - 2026 (USD Billion)
8.6.4 Others
8.6.4.1 Others Market, 2014 - 2026 (USD Billion)
8.7 CNS Conditions
8.7.1 CNS Conditions Market, 2014 - 2026 (USD Billion)
8.7.2 Epilepsy
8.7.2.1 Epilepsy Market, 2014 - 2026 (USD Billion)
8.7.3 Parkinson’s Disease
8.7.3.1 Parkinson’s Disease Market, 2014 - 2026 (USD Billion)
8.7.4 Huntington’s Disease
8.7.4.1 Huntington’s Disease Market, 2014 - 2026 (USD Billion)
8.7.5 Stroke
8.7.5.1 Stroke Market, 2014 - 2026 (USD Billion)
8.7.6 Traumatic Brain Injury
8.7.6.1 Traumatic Brain Injury Market, 2014 - 2026 (USD Billion)
8.7.7 ALS
8.7.7.1 ALS Market, 2014 - 2026 (USD Billion)
8.7.8 Muscle Regeneration
8.7.8.1 Muscle Regeneration Market, 2014 - 2026 (USD Billion)
8.7.9 Others
8.7.9.1 Others Market, 2014 - 2026 (USD Billion)
8.8 Diabetes
8.8.1 Diabetes Market, 2014 - 2026 (USD Billion)
8.9 Obesity
8.9.1 Obesity Market, 2014 - 2026 (USD Billion)
8.10 Others
8.10.1 Others Market, 2014 - 2026 (USD Billion)

Chapter 9 In Vivo CRO Market: Regional Analysis
9.1 In Vivo CRO Market: Definition & Scope
9.2 Regional Market Snapshot
9.3 Regional Market Share And Leading Players, 2018
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Latin America
9.3.5 Middle East & Africa
9.4 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.5 Middle East & Africa
9.5 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
9.6 North America
9.6.1 North America In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.6.2 U.S.
9.6.2.1 U.S. In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.6.3 Canada
9.6.3.1 Canada In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7 Europe
9.7.1 Europe In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7.2 France
9.7.2.1 France In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7.3 U.K.
9.7.3.1 U.K. In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7.4 Germany
9.7.4.1 Germany In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7.5 Italy
9.7.5.1 Italy In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.7.6 Spain
9.7.6.1 Spain In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8 Asia Pacific
9.8.1 Asia Pacific In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8.2 Japan
9.8.2.1 Japan In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8.3 China
9.8.3.1 China In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8.4 India
9.8.4.1 India In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8.5 Australia
9.8.5.1 Australia In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.8.6 South Korea
9.8.6.1 South Korea In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.9 Latin America
9.9.1 Latin America In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.9.2 Brazil
9.9.2.1 Brazil In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.9.3 Mexico
9.9.3.1 Mexico In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.9.4 Argentina
9.9.4.1 Argentina In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.9.5 Colombia
9.9.5.1 Colombia In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.10 MEA
9.10.1 MEA In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.10.2 South Africa
9.10.2.1 South Africa In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.10.3 Saudi Arabia
9.10.3.1 Saudi Arabia In Vivo CRO Market, 2014 - 2026 (USD Billion)
9.10.4 UAE
9.10.4.1 UAE In Vivo CRO Market, 2014 - 2026 (USD Billion)

Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact Analysis, By Key Market Participants
10.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
10.3 Vendor Landscape
10.3.1 List Of Key Distributors And Channel Partners
10.3.2 Key Customers
10.3.3 Key Company Market Share Analysis, 2018
10.4 Public Companies
10.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
10.4.2 Company Market Share/Ranking, By Region
10.4.3 Competitive Dashboard Analysis
10.4.3.1 Market Differentiators
10.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
10.5 Private Companies
10.5.1 List Of Key Emerging Companies’ /Technology Disruptors/Innovators
10.5.2 Funding Outlook (Optional)
10.5.3 Regional Network Map
10.5.4 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
10.6 Supplier Ranking

Chapter 11 Company Profiles
11.1 Strategic Framework
11.1.1 QUINTILES
11.1.1.1 Company Overview
11.1.1.2 Financial Performance
11.1.1.3 Service Benchmarking
11.1.1.4 Strategic Initiativees
11.1.2 CHARLES RIVER LABORATORIES
11.1.2.1 Company Overview
11.1.2.2 Financial Performance
11.1.2.3 Service Benchmarking
11.1.3 ICON PLC
11.1.3.1 Company Overview
11.1.3.2 Financial Performance
11.1.3.3 Service Benchmarking
11.1.3.4 Strategic Initiativees
11.1.4 COVANCE INC.
11.1.4.1 Company Overview
11.1.4.2 Financial Performance
11.1.4.3 Service Benchmarking
11.1.4.4 Strategic Initiativees
11.1.5 PAREXEL INTERNATIONAL
11.1.5.1 Company Overview
11.1.5.2 Financial Performance
11.1.5.3 Service Benchmarking
11.1.5.4 Strategic Initiativees
11.1.6 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
11.1.6.1 Company Overview
11.1.6.2 Financial Performance
11.1.6.3 Service Benchmarking
11.1.6.4 Strategic Initiativees
11.1.7 THEOREM CLINICAL RESEARCH
11.1.7.1 Company Overview
11.1.7.2 Financial Performance
11.1.7.3 Service Benchmarking
11.1.7.4 Strategic Initiativees
11.1.8 INVENTIV HEALTH
11.1.8.1 Company Overview
11.1.8.2 Financial Performance
11.1.8.3 Service Benchmarking
11.1.9 WUXI APPTEC, INC.
11.1.9.1 Company Overview
11.1.9.2 Financial Performance
11.1.9.3 Service Benchmarking
11.1.9.4 Strategic Initiativees
11.1.10 AMERICAN PRECLINICAL SERVICES, LLC.
11.1.10.1 Company Overview
11.1.10.2 Service Benchmarking
11.1.10.3 Strategic Initiativees
11.1.11 EVOTEC (US), INC.
11.1.11.1 Company Overview
11.1.11.2 Financial Performance
11.1.11.3 Service Benchmarking
11.1.11.4 Strategic Initiativees

Chapter 12 KOL Commentary

Chapter 13 Recommendation

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Quintiles
  • Charles River Laboratories
  • Icon Plc
  • Covance Inc.
  • Parexel International
  • Pharmaceutical Product Development, Llc (Ppd)
  • Theorem Clinical Research
  • Inventiv Health
  • Wuxi Apptec, Inc.
  • American Preclinical Services, Llc.
  • Evotec (Us), Inc.
Note: Product cover images may vary from those shown
Adroll
adroll